Biogen Inc. (BIT:1BIIB)
Italy flag Italy · Delayed Price · Currency is EUR
114.90
+3.90 (3.51%)
At close: Aug 13, 2025, 5:30 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Multiple Sclerosis
4.35B
Log In
Log In
Log In
Log In
Upgrade
Multiple Sclerosis Growth
-8.10%
Log In
Log In
Log In
Log In
Upgrade
Other
2.46B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
18.44%
Log In
Log In
Log In
Log In
Upgrade
Rare Disease
1.99B
Log In
Log In
Log In
Log In
Upgrade
Rare Disease Growth
13.66%
Log In
Log In
Log In
Log In
Upgrade
Biosimilars
793.10M
Log In
Log In
Log In
Log In
Upgrade
Biosimilars Growth
-2.17%
Log In
Log In
Log In
Log In
Upgrade
Alzheimer's Disease
-
Log In
Log In
Log In
Log In
Upgrade
Other Product
82.50M
Log In
Log In
Log In
Log In
Upgrade
Other Product Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
2.46B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
18.44%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
2.46B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
15.14%
Log In
Log In
Log In
Log In
Upgrade
United States
3.24B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
3.33%
Log In
Log In
Log In
Log In
Upgrade
International
3.98B
Log In
Log In
Log In
Log In
Upgrade
International Growth
-3.72%
Log In
Log In
Log In
Log In
Upgrade
Other
2.46B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
15.14%
Log In
Log In
Log In
Log In
Upgrade